Total Payments
$3,509
2024 Payments
$189.37
Companies
35
Transactions
241
Medicare Patients
39,745
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$3,481 (99.2%)
Education$27.78 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,481 | 239 | 99.2% |
| Education | $27.78 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $655.53 | 49 | $0 (2024) |
| ABBVIE INC. | $625.96 | 43 | $0 (2024) |
| PFIZER INC. | $372.06 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $246.14 | 12 | $0 (2021) |
| Amgen Inc. | $244.24 | 18 | $0 (2024) |
| Lilly USA, LLC | $226.64 | 16 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $189.75 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $107.42 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $102.55 | 9 | $0 (2022) |
| Amarin Pharma Inc. | $82.09 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.37 | 11 | ABBVIE INC. ($58.91) |
| 2023 | $521.53 | 35 | PFIZER INC. ($177.48) |
| 2022 | $675.12 | 43 | ABBVIE INC. ($215.58) |
| 2021 | $552.62 | 44 | AbbVie Inc. ($167.71) |
| 2020 | $313.18 | 21 | Novo Nordisk Inc ($93.09) |
| 2019 | $277.97 | 20 | Novo Nordisk Inc ($135.18) |
| 2018 | $413.09 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($82.69) |
| 2017 | $566.35 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($138.01) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $26.29 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: VACCINES | ||||||
| 12/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: PAIN | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation | ||||||
| 10/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 10/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: VACCINES | ||||||
| 09/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 8,487 | 14,107 | $1.2M | $480,342 |
| 2022 | 54 | 9,320 | 15,195 | $1.1M | $475,164 |
| 2021 | 54 | 10,940 | 17,514 | $1.2M | $567,352 |
| 2020 | 57 | 10,998 | 16,902 | $1.1M | $477,850 |
Total Patients
39,745
Total Services
63,718
Medicare Billing
$2.0M
Procedure Codes
216
All Medicare Procedures & Services
216 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 770 | 2,299 | $551,760 | $190,770 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 631 | 631 | $153,964 | $79,651 | 51.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 389 | 389 | $46,291 | $27,981 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 438 | $74,460 | $25,798 | 34.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 102 | 102 | $23,766 | $14,586 | 61.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 427 | 431 | $16,809 | $12,995 | 77.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 613 | 962 | $27,898 | $12,621 | 45.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 699 | 1,600 | $27,200 | $12,138 | 44.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 642 | 1,367 | $24,606 | $11,308 | 46.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 672 | 1,339 | $12,785 | $10,824 | 84.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 523 | 634 | $23,458 | $10,419 | 44.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 46 | 53 | $17,702 | $8,436 | 47.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 615 | 1,018 | $18,324 | $8,154 | 44.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $10,018 | $5,011 | 50.0% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 19 | 19 | $8,326 | $4,584 | 55.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 27 | 27 | $8,883 | $4,355 | 49.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 103 | 103 | $7,519 | $4,141 | 55.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 251 | 431 | $9,051 | $4,103 | 45.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 20 | 21 | $9,324 | $3,122 | 33.5% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 17 | 106 | $11,342 | $2,861 | 25.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 43 | 45 | $6,255 | $2,150 | 34.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 104 | 114 | $4,560 | $2,054 | 45.1% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 41 | 41 | $2,993 | $1,648 | 55.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 32 | $4,900 | $1,632 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 38 | $3,990 | $1,477 | 37.0% |
About Dr. Graham Powers, MD
Dr. Graham Powers, MD is a Family Medicine healthcare provider based in South Hill, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518965177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Graham Powers, MD has received a total of $3,509 in payments from pharmaceutical and medical device companies, with $189.37 received in 2024. These payments were reported across 241 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,481).
As a Medicare-enrolled provider, Powers has provided services to 39,745 Medicare beneficiaries, totaling 63,718 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 216 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location South Hill, VA
- Active Since 07/08/2005
- Last Updated 01/13/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518965177
Products in Payments
- Ozempic (Drug) $384.29
- UBRELVY (Drug) $218.09
- QULIPTA (Drug) $209.50
- JARDIANCE (Drug) $168.34
- ELIQUIS (Drug) $166.49
- VRAYLAR (Drug) $136.27
- TRULICITY (Drug) $131.46
- ENTRESTO (Drug) $107.42
- Otezla (Drug) $101.44
- TOUJEO (Drug) $95.78
- NURTEC ODT (Drug) $90.64
- Victoza (Drug) $83.89
- Vascepa (Drug) $82.09
- Aimovig (Biological) $78.29
- PREVNAR 20 (Biological) $77.23
- SYMBICORT (Drug) $67.69
- Tresiba (Drug) $57.81
- CHANTIX (Drug) $53.77
- NEXLETOL (Drug) $53.73
- Rybelsus (Drug) $53.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Hill
David Powers, Md, MD
Family Medicine — Payments: $5,835
Family Medicine $5,835
Dr. Mark Carreras, M.d, M.D
Family Medicine — Payments: $436.58
Family Medicine $436.58
Dr. Bryan Mosora, D.o, D.O
Family Medicine — Payments: $336.41
Family Medicine $336.41
Mahmethan Shadid, Md, MD
Family Medicine — Payments: $265.79
Family Medicine $265.79
Jill Allen, Md, MD
Family Medicine — Payments: $63.83
Family Medicine $63.83
Graham Keats, Md, MD
Family Medicine
Family Medicine